InnoCare get approval of Tafasitamab with Lenalidomide for the treatment of refractory diffuse large B-Cell lymphoma in Hong Kong
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
This rapid analytical technique provides additional information about the polymorph and solid-state properties of active pharmaceutical ingredients (APIs)
Company creates Younger T Cells for fighting cancer using its NR2F6 technology
Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'
Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta
The sale is expected to close in the first quarter of 2022
Urban, semi-urban and remote corners of the country will be catered using drone delivery technology
Takes charge to lead business innovation, strategy, alliance & partnerships
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
Subscribe To Our Newsletter & Stay Updated